Sign in

CIK 0001601830

  • Large accelerated filer

RECURSION PHARMACEUTICALS, INC.

Sign in to watch
Ticker
RXRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464099738
Phone
+1 385-269-0203
Business address
41S RIO GRANDE STREET, SALT LAKE CITY, UT, 84101
Former names
Recursion Pharmaceuticals, LLC
  1. 4 Grant or award Director acquired 88,424 shares (grant or award)
  2. 4 Grant or award Director acquired 88,424 shares (grant or award)
  3. 4 Grant or award Director acquired 88,424 shares (grant or award)
  4. 4 Grant or award Director acquired 88,424 shares (grant or award)
  5. 4 Grant or award Director acquired 88,424 shares (grant or award)
  6. 4 Grant or award Director acquired 88,424 shares (grant or award)
  7. 4 Planned sale Director sold 3,963 shares at $3.18 ($12,602)
  8. 4 Shares withheld for taxes Chief Financial Officer gave up 5,396 shares (to pay taxes)
  9. 4 Planned sale Director sold 40,000 shares at $3.62 ($144,800)
  10. 4 Planned sale CEO and President sold 23,588 shares at $3.58 ($84,459)
  11. 4 Planned sale Director sold 4,386 shares at $3.54 ($15,526)
  12. 4 Planned sale Director sold 30,000 shares at $3.68 ($110,400)
  13. 4 Planned sale Director sold 40,000 shares at $3.08 ($123,200)
  14. 4 Shares withheld for taxes Chief Scientific Officer gave up 26,657 shares (to pay taxes)
  15. 4 Shares withheld for taxes CEO and President gave up 62,701 shares (to pay taxes)
  16. 4 Shares withheld for taxes Chief Financial Officer gave up 25,018 shares (to pay taxes)
  17. 4 Shares withheld for taxes Director gave up 22,821 shares (to pay taxes)
  18. 4 Planned sale Director sold 40,000 shares at $3.37 ($134,800)
  19. 4 Planned sale Director sold 30,000 shares at $3.52 ($105,600)
  20. 4 Planned sale Director sold 40,000 shares at $3.61 ($144,400)

Page 2 of 26 · 512 filings